|
|
 |
|
Total Number of Holdings (excluding cash): 29
| Gilead Sciences, Inc. |
GILD |
375558103 |
Pharmaceuticals |
48,492 |
$4,265,356.32 |
9.89% |
| Bristol-Myers Squibb Company |
BMY |
110122108 |
Pharmaceuticals |
45,658 |
$3,648,987.36 |
8.46% |
| Amgen Inc. |
AMGN |
031162100 |
Pharmaceuticals |
12,808 |
$3,628,378.32 |
8.41% |
| Ironwood Pharmaceuticals, Inc. |
IRWD |
46333X108 |
Pharmaceuticals |
286,041 |
$3,406,748.31 |
7.90% |
| Johnson & Johnson |
JNJ |
478160104 |
Pharmaceuticals |
19,076 |
$3,359,283.60 |
7.79% |
| Merck & Co., Inc. |
MRK |
58933Y105 |
Pharmaceuticals |
18,029 |
$1,963,898.97 |
4.55% |
| Eli Lilly and Company |
LLY |
532457108 |
Pharmaceuticals |
5,109 |
$1,882,870.86 |
4.37% |
| United Therapeutics Corporation |
UTHR |
91307C102 |
Pharmaceuticals |
6,791 |
$1,878,390.60 |
4.36% |
| AbbVie Inc. |
ABBV |
00287Y109 |
Pharmaceuticals |
11,445 |
$1,873,775.40 |
4.35% |
| Prestige Consumer Healthcare Inc. |
PBH |
74112D101 |
Pharmaceuticals |
30,425 |
$1,851,665.50 |
4.29% |
| Viatris Inc. |
VTRS |
92556V106 |
Pharmaceuticals |
161,141 |
$1,761,271.13 |
4.08% |
| Cardinal Health, Inc. |
CAH |
14149Y108 |
Pharmaceuticals |
21,761 |
$1,727,823.40 |
4.01% |
| Vertex Pharmaceuticals Incorporated |
VRTX |
92532F100 |
Pharmaceuticals |
5,462 |
$1,703,106.22 |
3.95% |
| Pfizer Inc. |
PFE |
717081103 |
Pharmaceuticals |
34,024 |
$1,691,333.04 |
3.92% |
| Organon & Co. |
OGN |
68622V106 |
Pharmaceuticals |
53,940 |
$1,410,531.00 |
3.27% |
| Horizon Therapeutics Plc |
HZNP |
G46188101 |
Pharmaceuticals |
9,282 |
$898,961.70 |
2.08% |
| BioMarin Pharmaceutical Inc. |
BMRN |
09061G101 |
Pharmaceuticals |
6,162 |
$629,879.64 |
1.46% |
| Alkermes Plc |
ALKS |
G01767105 |
Pharmaceuticals |
23,220 |
$580,500.00 |
1.35% |
| Zoetis Inc. |
ZTS |
98978V103 |
Pharmaceuticals |
3,511 |
$537,358.55 |
1.25% |
| Jazz Pharmaceuticals Plc |
JAZZ |
G50871105 |
Pharmaceuticals |
3,541 |
$530,902.13 |
1.23% |
| Ionis Pharmaceuticals, Inc. |
IONS |
462222100 |
Pharmaceuticals |
12,926 |
$491,575.78 |
1.14% |
| Pacira BioSciences, Inc. |
PCRX |
695127100 |
Pharmaceuticals |
10,473 |
$491,916.81 |
1.14% |
| Corcept Therapeutics Incorporated |
CORT |
218352102 |
Pharmaceuticals |
21,286 |
$486,597.96 |
1.13% |
| Perrigo Company Plc |
PRGO |
G97822103 |
Pharmaceuticals |
14,688 |
$466,050.24 |
1.08% |
| Elanco Animal Health Incorporated |
ELAN |
28414H103 |
Pharmaceuticals |
36,326 |
$456,617.82 |
1.06% |
| Seagen Inc. |
SGEN |
81181C104 |
Pharmaceuticals |
3,562 |
$419,995.42 |
0.97% |
| Blueprint Medicines Corporation |
BPMC |
09627Y109 |
Pharmaceuticals |
7,506 |
$364,116.06 |
0.84% |
| Catalent, Inc. |
CTLT |
148806102 |
Pharmaceuticals |
6,245 |
$301,133.90 |
0.70% |
| Emergent BioSolutions Inc. |
EBS |
29089Q105 |
Pharmaceuticals |
22,881 |
$278,919.39 |
0.65% |
| US Dollar |
$USD |
|
Other |
131,449 |
$131,448.59 |
0.30% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|